Search result of BIOTECH

BIO aims to assist scientists, patients, and biotech founders in building on-chain scientific communities, offering support in areas such as tokenomics design, community development, funding, and liquidity. Upcoming projects on BIO Launchpad include Curetopia, Long COVID Labs, and Quantum Biology DAO.

Bio Protocol ($BIO) is a decentralized platform driving biotech innovation through BioDAOs, IP tokenization, and community governance.

Click to discover the five most popular DeSci projects in the year 2024 and how they are contributing to the advancement of scientific research.

BIO Protocol, often referred to as the on-chain science version of Y Combinator, aims to leverage blockchain technology to bring transparency and decentralization to the scientific research and funding process. The article provides a detailed overview of the core components of BIO Protocol, including BioDAO, the curation system, liquidity and IP tokenization, as well as its tokenomics and distribution strategy.

MEI Pharma, a publicly traded US biotechnology firm, has established a strategic Litecoin treasury and appointed Litecoin founder Charlie Lee to its board of directors. The company is also launching a $100 million blockchain transformation initiative. MEI Pharma is the first US-listed company to add LTC to its financial reserves. This signals the expansion of the MicroStrategy-style treasury strategy to include Litecoin. As anticipation builds around spot ETF developments, LTC could become a key asset in the next wave of institutional investment.

This article gives a detailed introduction to the list of key DeSci ecological projects and their recent developments.

The article explores the DeSci (Decentralized Science) track and its potential projects, highlighting DeSci's potential to leverage Web3 technology to enable the equitable funding, creation, review, storage, and dissemination of scientific knowledge.DeSci encourages scientists to openly share research results while allowing anyone to access and contribute. The article mentions the rise of ResearchCoin (RSC) and the boom in DAOs in DeSci projects that solve the research funding challenge.DeSci projects such as Molecule, VitaDAO, and HairDAO focus on biotechnology and utilize blockchain technology to streamline data collection and processing to advance science.DeSci also provides new ways to solve the challenges of peer review and research funding audits.

This article analyzes how decentralized science (DeSci) introduces the liquidity of Meme coins into scientific research to support real scientific exploration. The article analyzes the business models of Bio Protocol and Pump.Science and discusses the real needs and market of DeSci. potential, and discuss how DeSci balances long-term investment in scientific research with short-term speculation in the crypto market, as well as the future development direction of DeSci's narrative.

BIO Protocol is a new financial layer for decentralized science (DeSci), aiming to accelerate the flow of capital and talent into the field of on-chain science. The protocol aims to catalyze the on-chain economy of the scientific community (BioDAOs) and create a deep, liquid, and efficient market for scientific knowledge assets developed by BioDAOs.

Nasdaq Composite Index News: Tech Stocks Propel U.S. Markets to Record Highs—Discover the Major Drivers and Trends, and learn how new investors can quickly identify market direction and investment opportunities.

Decentralised Science is a new paradigm that promises to rebuild scientific research on stronger foundations. The current spotlight of DeSci projects focuses on pharmaceutical drugs, one of the low-hanging fruits for improving the most important resource for humanity - our health.

This article will explore how AxonDAO, an early project of DeSci, utilizes biometrics, blockchain, and AI technology, combined with DePIN, to reshape digital healthcare and promote citizen science.

In the first half of 2025, 58% of global venture capital flowed into AI, with giants like OpenAI dominating. This article provides a detailed analysis of funding trends, stage distribution, regional disparities, and regulatory expectations, while predicting the H2 outlook: a mix of bubbles and inflection points, where execution will determine the fate of AI startups. Essential reading for investors, entrepreneurs, and industry observers seeking in-depth insights.

Analyzing the latest mergers involving BSTR, Twenty One, and Cantor, we examine the value of shell companies, the reflexivity flywheel effect, and emerging bubbles, while also advising investors to stay alert to the risk of premiums receding.

This article introduces Molecule and its ecosystem's involvement in the decentralized science (DeSci) field, including advancing IP tokenization funding through the Catalyst platform, driving biotechnology project development with the BIO Protocol, and supporting barrier-free scientific experiments and fundraising via the pump.science platform. It also explores the potential and challenges of DeSci.